This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.


Introduction: Optimizing Treatment Outcome in Depression

Maurizio Fava, MD

Published: February 28, 2000

Article Abstract

Because this piece does not have an abstract, we have provided for your benefit the first 3 sentences of the full text.

Many effective therapies, including pharmacotherapy, psychotherapy, and electroconvulsive treatment, are available for patients suffering from unipolar depressive disorders. Antidepressant drugs have become first-line treatment for depression in both primary and specialty care settings. Despite the improved safety and tolerability of newer antidepressants compared with tricyclic antidepressants and monoamine oxidase inhibitors, many patients do not adhere to antidepressant treatment.’ ‹

Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Related Articles

Volume: 61

Quick Links: Depression (MDD)

Sign-up to stay
up-to-date today!


Already registered? Sign In

Case Report

Safety and Tolerability of Concomitant Intranasal Esketamine Treatment With Irreversible, Nonselective MAOIs: A Case Series

Three cases suggest that concomitant use of intranasal esketamine with an irreversible, nonselective MAOI is safe in...